Osaic Holdings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$268 7933
2025
Q3
$268 Hold
1
﹤0.01% 7660
2025
Q2
$980 Hold
1
﹤0.01% 7154
2025
Q1
$460 Hold
1
﹤0.01% 7008
2024
Q4
$1.13K Sell
1
-1
-50% -$74 ﹤0.01% 6802
2024
Q3
$915 Hold
2
﹤0.01% 6870
2024
Q2
$4.67K Hold
2
﹤0.01% 6210
2024
Q1
$9.57K Hold
2
﹤0.01% 5764
2023
Q4
$7.63K Buy
2
+1
+100% +$102 ﹤0.01% 5972
2023
Q3
$1.17K Hold
1
﹤0.01% 6786
2023
Q2
$3.16K Buy
+1
New +$121 ﹤0.01% 6496
2022
Q1
Sell
-4
Closed -$10K 7300
2021
Q4
$10K Buy
+4
New +$575 ﹤0.01% 6234

Other funds holding DXCM

Osaic Holdings's DXCM Position: Q1 2026 in Review

Osaic Holdings increased its DexCom (DXCM) stake by 14% in Q1 2026, buying an estimated $387K and bringing the position to 44,377 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

Osaic Holdings first reported a position in DXCM in Q1 2020 and has held it in 25 quarters since. The position peaked at $18.6M in Q3 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Osaic Holdings held 44,377 shares of DexCom worth $2.79M as of Q1 2026.
  • Osaic Holdings bought 5,563 DexCom shares in Q1 2026, an estimated $387K.
  • DexCom made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #1802 holding.
  • Osaic Holdings first reported a position in DexCom in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's DexCom position peaked at $18.6M in Q3 2021.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.